Results 11 to 20 of about 25,370 (217)

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial

open access: yesJournal of Arrhythmia, 2020
Background EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation evaluated use of nonvitamin K antagonist oral anticoagulant edoxaban vs enoxaparin‐warfarin in patients with nonvalvular atrial fibrillation undergoing ...
Gregory Y. H. Lip   +8 more
doaj   +2 more sources

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea

open access: yesUpsala Journal of Medical Sciences, 2017
Background: Sleep apnea is common in patients with atrial fibrillation, but the effect of the cardioversion of atrial fibrillation to sinus rhythm on central and obstructive apneas is mainly unknown.
Niklas Höglund   +4 more
doaj   +2 more sources

Cardioversion: What to choose? Etomidate or propofol

open access: yesAnnals of Cardiac Anaesthesia, 2015
Context: Electrical cardioversion is a short painful procedure to regain normal sinus rhythm requiring anaesthesia for haemodynamic stability, sedation, analgesia and early recovery.
Pushkar M Desai   +2 more
doaj   +2 more sources

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation

open access: yesMedicina, 2022
Atrial fibrillation (AF) is the most frequent chronic arrhythmia worldwide, and it is associated with significant morbidity and mortality, making it a considerable burden both to patients and the healthcare system.
Marco Valerio Mariani   +7 more
doaj   +1 more source

Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients. [PDF]

open access: yesPLoS ONE, 2018
The relative efficacy of antiarrhythmic drugs (AADs) after electrical cardioversion are not well established. This study aimed to investigate the efficacies of different AADs for maintaining sinus rhythm (SR) after electrical cardioversion for atrial ...
Hye Bin Gwag   +6 more
doaj   +1 more source

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers [PDF]

open access: yes, 2012
BACKGROUND Atrial fibrillation is a serious public health problem posing a considerable burden to not only patients, but the healthcare environment due to high rates of morbidity, mortality, and medical resource utilization. There are limited data on the
Rosenqvist Mårten   +63 more
core   +2 more sources

EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER)

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To study efficacy and safey of sinus rhythm restoration with amiodarone and propafenone in outpatients with recurrent atrial fibrillation (AF), and to estimate pharmacoeconomic efficiency of such cardioversion in comparison with hospital treatment ...
T. A. Istomina   +6 more
doaj   +1 more source

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)

open access: yesOpen Heart, 2021
Introduction Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide. Direct current cardioversion is commonly used to restore sinus rhythm in patients with AF.
David Ferreira   +11 more
doaj   +1 more source

Rivaroxaban in atrial fibrillation cardioversion: an update [PDF]

open access: yes, 2019
Carlo Lavalle, Martina Straito, Annalisa Caroli, Agostino Piro, Giuseppe Giunta, Marco Valerio Mariani, Francesco FedeleDepartment of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, “Sapienza” University ...
Giunta G   +13 more
core   +1 more source

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation [PDF]

open access: yes, 2019
To the Editor: Pluymaekers et al. (April 18 issue)(1) evaluated the occurrence of spontaneous cardioversion in patients with recent-onset (<36 hours) atrial fibrillation. The proposed wait-and-see approach included cardioversion within 48 hours in the
Biffi, M, Boriani, G
core   +5 more sources

Home - About - Disclaimer - Privacy